• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prolonged neutrophilia is associated with worse outcomes after Esophagectomy.

作者信息

Bostock Ian C, Zhou Nicolas, Antonoff Mara B, Murphy Mariela Blum, Lin Steven, Maru Dipen, Mehran Reza, Rajaram Ravi, Rice David, Sepesi Boris, Swisher Stephen, Vaporciyan Ara, Walsh Garrett, Hofstetter Wayne

机构信息

Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Dis Esophagus. 2022 Apr 19;35(4). doi: 10.1093/dote/doab081.

DOI:10.1093/dote/doab081
PMID:34897440
Abstract

Neutrophilia is a potential biomarker for postoperative complications and oncologic outcomes. There is a paucity of data regarding neutrophilia in patients with esophageal adenocarcinoma. Our Institutional Database was queried for esophageal adenocarcinoma patients who underwent esophagectomy from 2006 to 2019. Complete blood counts (CBC), demographic characteristics, perioperative and oncologic outcomes were evaluated. Two groups were created based on the presence of prolonged neutrophilia (PN, >7,000 absolute neutrophils 90 days after surgery). Univariate, multivariable, and survival analysis were performed (P-value < 0.05). We identified 686 patients with complete CBC data: 565 in the no prolonged neutrophilia (NPN) and 121 in the PN groups (17.6%). The mean age was 54 versus 48 years in the NPN and PN groups (P = 0.01). There was no difference in height, weight, gender, race, tumor size, histology, pTNM, PS, ASA, salvage procedure, neoadjuvant treatment and comorbidities. On multivariable analysis, the PN group had increased transfusions (19.8% vs. 11.9%; P = 0.02), aspiration (13.2% vs. 2.5%; P = 0.002), pulmonary embolus (3.3% vs. 0.4%; P = 0.02), cardiac arrest (5% vs. 0.4%; P = 0.02) and hematologic complications (23.1% vs. 12.6%; P = 0.01). After controlling for any postoperative complication, PN had increased distant recurrence (24% vs. 12.7%; hazard ration [HR]: 2.3, 95% confidence interval [CI] 1.42-3.9; P = 0.001) and decreased OS (33.8% vs. 49.7%, HR: 1.83, 95% CI: 1.19-2.81; P = 0.006); median follow up 77 months (46-109). PN was predictive of distant recurrence and decreased overall survival. Further work investigating these neutrophil populations represents a potential area for biomarker research, immunomodulation, and may guide postoperative surveillance strategies.

摘要

相似文献

1
Prolonged neutrophilia is associated with worse outcomes after Esophagectomy.
Dis Esophagus. 2022 Apr 19;35(4). doi: 10.1093/dote/doab081.
2
Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?食管癌新辅助治疗会增加术后发病率或死亡率吗?
Dis Esophagus. 2015 Oct;28(7):644-51. doi: 10.1111/dote.12251. Epub 2014 Jul 24.
3
Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.放化疗后延迟与及时行食管癌切除术治疗食管腺癌的结果。
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2555-2566. doi: 10.1016/j.jtcvs.2019.09.169. Epub 2019 Oct 22.
4
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.术前中性粒细胞与淋巴细胞比值升高可预测食管癌术后疾病复发。
Ann Surg Oncol. 2011 Nov;18(12):3362-9. doi: 10.1245/s10434-011-1754-8. Epub 2011 May 6.
5
Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.新辅助放化疗后食管癌食管切除术后病理完全缓解患者复发的预测因素:一项多中心研究
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1357-64. doi: 10.1245/s10434-015-4619-8. Epub 2015 May 27.
6
Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer.新辅助放化疗及手术治疗食管癌后局部区域复发模式及相关因素
J Surg Oncol. 2018 Feb;117(2):150-159. doi: 10.1002/jso.24808. Epub 2017 Aug 22.
7
Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.新辅助治疗后开放与微创Ivor Lewis食管癌切除术的疗效
Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062. Epub 2015 Dec 1.
8
Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.临床分期为淋巴结阴性的食管腺癌与新辅助放化疗带来的总生存获益之间的关联
JAMA Surg. 2016 Mar;151(3):234-45. doi: 10.1001/jamasurg.2015.4068.
9
Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.新辅助化疗后行食管癌切除术患者骨骼肌量测量对临床结局的影响。
Surgery. 2019 Dec;166(6):1041-1047. doi: 10.1016/j.surg.2019.07.033. Epub 2019 Oct 11.
10
Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.新辅助治疗反应对局部晚期食管腺癌的预后价值。
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1682-1693.e1. doi: 10.1016/j.jtcvs.2018.11.131. Epub 2018 Dec 15.

引用本文的文献

1
Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in Esophageal Squamous Cell Carcinoma.卷曲螺旋结构域包含蛋白25在食管鳞状细胞癌中的表达的临床意义
Ann Surg Oncol. 2025 May;32(5):3839-3850. doi: 10.1245/s10434-025-16964-z. Epub 2025 Feb 14.